Concepedia

Y. Lee

YL

Statistics

Publications

2

Citations

195

H-Index

2

Active since

2011

Affiliations

University of California, San Francisco(Current)

Y. Lee is an author at University of California, San Francisco specializing in pharmacology, met inhibitors, and cancer pharmacology.

Publications per year

2011–2017

2

Publications

2

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study

Robin Kate Kelley, Chris Verslype, Allen Lee Cohn et al. · Annals of Oncology · 2017 · 137 citations · Full text

, , +13

Activity of cabozantinib (XL184) in soft tissue and bone: Results of a phase II randomized discontinuation trial (RDT) in patients (pts) with advanced solid tumors.

Michael Gordon, Nicholas J. Vogelzang, Patrick Schöffski et al. · Journal of Clinical Oncology · 2011 · 58 citations

, , +17

1–2 of 2